(Q33239626)

24 July 2017

1 reference

title

MG7 mimotope-based DNA vaccination for gastric cancer (English)

1 reference

24 July 2017

0 references

Dexin Zhang

1

1 reference

24 July 2017

Yu Chen

series ordinal

2

1 reference

24 July 2017

Daiming Fan

series ordinal

3

1 reference

24 July 2017

publication date

1 April 2006

1 reference

Expert Review of Vaccines

24 July 2017

published in

1 reference

24 July 2017

volume

5

1 reference

24 July 2017

issue

2

1 reference

24 July 2017

page(s)

223-231

1 reference

Tumor-associated antigens: from discovery to immunity

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Therapeutic vaccines against melanoma and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Preparation of antigastric cancer monoclonal antibody MGb2-mitomycin C conjugate with improved antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Adventures with an enigmatic anticancer drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

A new era for cancer immunotherapy based on the genes that encode cancer antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Development of an oral DNA vaccine against MG7-Ag of gastric cancer using attenuated salmonella typhimurium as carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Oral attenuated Salmonella typhimurium vaccine against MG7-Ag mimotope of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

CpG DNA and cancer immunotherapy: orchestrating the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Immunostimulatory DNA sequences and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

CpG DNA and LPS induce distinct patterns of activation in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Gene therapy progress and prospects: nonviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Immunodominance and tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Prophylactic, therapeutic and anti-metastatic effects of an HPV-16mE6Delta/mE7/TBhsp70Delta fusion protein vaccine in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Proteasomal targeting and minigene repetition improve cell-surface presentation of a transfected, modified melanoma tumour antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Recombinant fusion peptides containing single or multiple repeats of a ubiquitous T-helper epitope are highly immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Heat shock protein 70-associated peptides elicit specific cancer immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Heat shock protein-peptide complexes in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Human homologue of murine tumor rejection antigen gp96: 5'-regulatory and coding regions and relationship to stress-induced proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Heat shock proteins: the fountainhead of innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Immunotherapy of human cancer: lessons from mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

A phase II study of G17DT in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Identification of immunoglobulin superfamily 11 (IGSF11) as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes cytotoxic T-lymphocyte (CTL) epitopes capable of inducing human leukocyte antigen-A33-restricted and tumor-reactive CTLs in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

G17DT--a new weapon in the therapeutic armoury for gastrointestinal malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Bird's-eye view on gastric cancer research of the past 25 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Gene gun-mediated intracutaneous vaccination with papillomavirus E7 gene delays cancer development of papillomavirus-induced skin papillomas on rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Immunohistochemical study of monoclonal antibody MGD-1 in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Tumor-Associated Carbohydrate Antigens Defining Tumor Malignancy: Basis for Development of Anti-Cancer Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

A novel DNA vaccine containing four mimicry epitopes for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Enhancement of antigen-presenting ability of B lymphoma cells by immunostimulatory CpG-oligonucleotides and anti-CD40 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Silencing of immunodominant epitopes by contiguous sequences in complex synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Association of peptides with heat shock protein gp96 occurs in vivo and not after cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

CD91: a receptor for heat shock protein gp96

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.223

21 January 2018

Identifiers

DOI

10.1586/14760584.5.2.223

1 reference

24 July 2017

1 reference